Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2008 Standout
Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy
1996
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Management of the obstetric antiphospholipid syndrome
2004
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2011 Standout
Coagulation abnormalities in idiopathic portal venous thrombosis
1999
Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant Therapy
2000
Kinetics of the reactive cell clones after immunosuppression and induction of tolerance. II. Different recovery of 19 S and 7 S plaque‐forming cells after induction of tolerance
1975
Treatment of dermatomyositis and polymyositis
2002
Management and outcome of pregnancy in women with thrombophylic disorders and past cerebrovascular events
2002
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
2014 Standout
Clinical Epidemiological Quality in Molecular Genetic Research
1999
Juvenile idiopathic arthritis
2007 Standout
Biologic Rhythms in the Immune System
1999
The controversy over homocysteine and cardiovascular risk
2000
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study
2006
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
2008 Standout
Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Vascular disorders of the liver # †
2008 Standout
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
2007 Standout
Chronic myelogenous leukemia: A review
1996
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials
2002
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
2002 Standout
Pre-eclampsia
2005 Standout
Epidemiology of the Antiphospholipid Antibody Syndrome
2000
Circadian control of the immune system
2013 Standout
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
The Antiphospholipid Syndrome
2002 Standout
Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
2000
A comprehensive review of genetic association studies
2002
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
2001 Standout
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
1990
Prevention of Venous Thromboembolism
2004 Standout
Pre-eclampsia
2010 Standout
The use of methotrexate in childhood rheumatic diseases
1998
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal investigation of thromboembolism etiology (LITE)
2003
High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis
2001
Obstetric Complications in Patients with Hereditary Thrombophilia Identified Using the LCx Microparticle Enzyme Immunoassay
2007
Sex differences in autoimmune disease
2001 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Thrombophilia and pregnancy
2003
Laboratory diagnosis of the antiphospholipid syndrome
2002
Current Concepts in the Idiopathic Inflammatory Myopathies: Polymyositis, Dermatomyositis, and Related Disorders
1989
Recurrent miscarriage
2006 Standout
Genome-wide association studies for common diseases and complex traits
2005 Standout
Thrombophilia in pregnancy: a systematic review
2005
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study
2000
Polymyositis and dermatomyositis
2003 Standout
Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations
2013
How much warfarin is enough in APS related thrombosis?
2004
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis
1993 Standout
Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up
2013
The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant
2000
Factor V Leiden related Budd-Chiari syndrome
2001
Treatment of corticosteroid-resistant polymyositis with methotrexate
1971
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
The Complex Role of Estrogens in Inflammation
2007 Standout
The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.
2000
Functional Specificity of Antigen‐Binding Receptors of Lymphocytes
1970
Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis
2006
Polymyositis and Dermatomyositis
1975 Standout
Inflammatory Muscle Diseases
2015 Standout
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
2005
Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke
2002
Immunology and Clinical Importance of Antiphospholipid Antibodies
1991
Polymyositis and Dermatomyositis: Combined Methotrexate and Corticosteroid Therapy
1974
Factor V Leiden and Antiphospholipid Antibodies in Either Mothers or Infants Increase the Risk for Perinatal Arterial Ischemic Stroke
2008
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Reversal of Chronic Polymyositis Following Intravenous Immune Serum Globulin Therapy
1987
Guidelines for the Primary Prevention of Stroke
2014 Standout
Optical Imaging of Matrix Metalloproteinase-7 Activity in Vivo Using a Proteolytic Nanobeacon
2008
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Antiphospholipid antibodies and venous thromboembolism
1995
Inherited Thrombophilia as a Risk Factor for the Development of Ischemic Stroke in Young Adults
2000
CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS
1978 Standout
The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant
2000
Chronobiology in hematology and immunology
1983
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
CARRIER FUNCTION IN ANTI-HAPTEN ANTIBODY RESPONSES
1971 StandoutNobel
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors – a multicentre case–control study
2000
SYSTEMIC LUPUS ERYTHEMATOSUS AND PREGNANCY
1994
Immunological Unresponsiveness
1973
The Epidemiology of Venous Thromboembolism
2003 Standout
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.
2003
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Binding of Thymus- and Bone Marrow-Derived Lymphoid Cells to Antigen-Derivatized Fibers
1972 StandoutNobel
Dermatomyositis and Malignancy
1976
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Lupus Anticoagulant (LA) Testing: Performance of Clinical Laboratories Assessed by a National Survey Using Lyophilized Affinity-purified Immunoglobulin with LA Activity
2003
Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
2003
The Risk of Abortion and Stillbirth in Antithrombin-, Protein C-, and Protein S-deficient Women
1996
Detection of Antinuclear Antibodies by Use of an Enzyme Immunoassay with Nuclear HEp-2 Cell Extract and Recombinant Antigens: Comparison with Immunofluorescence Assay in 307 Patients
2001 StandoutNobel
Requirement of Vascular Integrin α v β 3 for Angiogenesis
1994 StandoutScience
IMMUNOLOGICAL MEMORY IN MICE
1972
Subtractive immunization yields monoclonal antibodies that specifically inhibit metastasis
1993
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Lupus Pregnancy
2003
Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis
1997
A rapid method for the isolation of functional thymus‐derived murine lymphocytes
1973 Standout
Works of Amira Many being referenced
Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia
2001
The Effect of Cyclophosphamide Pulses on Fertility in Patients With Lupus Nephritis
1992
Lymphoma with Recurrent Cycles of Spontaneous Remission and Relapse — Possible Role of Apoptosis
1995
Fetal Demise Associated with Lupus Anticoagulant: Clinical Features and Results of Treatment
1989
Treatment of Patients With Antiphospholipid Antibodies During Pregnancy
1992
Detection and Quantitative Evaluation of Lupus Circulating Anticoagulant Activity
1987
Cyclic Leukocytosis and Long Survival in Chronic Myeloid Leukemia
1983
On the mechanism of immunological tolerance in cyclophosphamide-treated mice.
1970
Low Molecular Weight Heparin and Warfarin in the Treatment of Patients with Antiphospholipid Syndrome during Pregnancy
2001
Periodicity During Recovery of Immune Response After Cyclophosphamide Treatment
1971
Single and Combined Prothrombotic Factors in Patients With Idiopathic Venous Thromboembolism
1999
TREATMENT OF DERMATOMYOSITIS WITH METHOTREXATE
1968
Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome.
1991
Circulating Anticoagulant in Systemic Lupus erythematosus: Clinical Manifestations
1986
Drug-Induced Immunologic Tolerance: Site of Action of Cyclophosphamide
1970